Manning Paul B: insider buys
Every open-market stock purchase reported by Manning Paul B to the SEC on Form 4.
Total bought$20.49M
Purchases2
Companies2
Last purchase filedFeb 26, 2026
Return on these buys-10%
Manning Paul B has made 2 open-market purchases worth $20.49M in 2 companies since Nov 25, 2025, according to SEC Form 4 filings. The most recent was filed on Feb 26, 2026: 550,458 shares of CADL at $5.45 (Director), worth $3M. The largest was $17.49M of VRCA on Nov 25, 2025. Taken together, these purchases are down 10% at the latest closing prices (split-adjusted, weighted by amount).
Companies Manning Paul B bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | Director, 10% Owner | 1 | $17.49M | -21% | Nov 25 |
| CADL | Candel Therapeutics, Inc. | Director | 1 | $3M | +53% | Feb 26 |
Get the next Manning Paul B purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Feb 26 | CADLCandel Therapeutics, Inc. | Manning Paul BDirector | $3M | 550,458 | $5.45 | +53% | +25% | Feb 23 | SEC |
| Nov 25 | VRCAVerrica Pharmaceuticals Inc. | Manning Paul BDirector, 10% Owner | $17.49M | 4,126,142 | $4.24 | -21% | — | Nov 25 | SEC |